Polycythemia vera
Jump to navigation
Jump to search
Clinical criteria
JAK2 mutations
[1], specifically at the V617F locus, give rise to myeloproliferative disorders such as essential thrombocythemia and polycythemia vera.
Authors [2] that other mutations of the coding region of the JAK2 gene could create a polycythemia phenotype.
[2]Scott, et al. New Engl J Med 356: 459-468 2007. [1]James, et al. Nature 434:1144-8 2005.